-
2022-501417-31-00
5
High-risk Resected Melanoma
-
2022-501463-40-00
5
Locally Advanced or Metastatic Cholangiocarcinoma
-
2022-502185-24-00
5
Schizophrenia, schizoaffective disorder, schizophreniform disorder, ma
-
2022-502777-42-00
5
Hypercholesterolemia
-
2023-506014-47-00
9
Resected (R0 or R1) pancreatic ductal adenocarcinoma
-
2023-507633-21-00
5
Neurological Disease
-
2025-521764-35-00
5
acute pharyngitis
-
2023-507427-28-00
5
seasonal allergic rhinitis and/or rhinoconjunctivitis
-
2024-511168-10-00
4
Primary or Secondary Progressive Multiple Sclerosis
-
2024-513445-37-00
5
previously untreated RT, irrespective of risk factors and disease stag
-
2024-513740-28-00
5
Respiratory Syncytial Virus and Human Metapneumovirus
-
2024-514682-19-00
5
Resected pancreatic ductal adenocarcinoma
-
2024-517269-18-00
5
stage III colon adenocarcinoma with deficient MMR
-
2024-517295-37-00
5
low and intermediate risk neuroblastoma
-
2024-517310-15-00
3
Parkinson's Disease
-
2024-517520-19-00
10
Patients with moderate-to-severe allergic rhinitis / rhinoconjunctivit
-
2024-518026-32-00
5
Invasive Breast Cancer
-
2024-518786-10-01
4
Moderate to Severe Chronic Spontaneous Urticaria
-
2024-518821-13-00
4
Non-cystic Fibrosis Bronchiectasis
-
2024-519504-27-00
5
Relapsed Refractory Multiple Myeloma
-
2024-519818-31-01
5
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2024-520068-32-00
6
Type 2 diabetes
-
2024-520117-50-00
4
Atopic Dermatitis
-
2024-520218-23-00
10
Pulmonary Arterial Hypertension